TEVA 4 posts

• Mylan/Viatris and Teva at the 38th Annual J.P. Morgan Healthcare Conference
  16 January 2020  ·  generics MYL Mylan
  Mylan presented on Viatris at the 38th Annual J.P. Morgan Healthcare Conference. Below are selected slides from the presentations of Mylan and Teva at the conference and figures comparing the existing business entities prior to the merger with Upjohn.
• Teva and status on CGRP migraine drugs
  7 August 2019  ·  pharma TEVA CGRP
  Teva Pharmaceuticals issued a press release on their Q2 earnings on August 7th.
• Teva still suffers from negative revenue growth and return to growth is still distant
  2 May 2019  ·  Ajovy Austedo Copaxone
• Teva and the approval of the migraine drug Ajovy®
  23 September 2018  ·  Eli Lilly Aimovig Ajovy